Marina Kolesnichenko

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Breast Cancer Risk

Top Venues

The EMBO journal

The Journal of pathology

Development (Cambridge, England)

Scripps Research Institute (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Scripps Research Institute

United States

PHD :: Molecular Medicine

University of Oxford

United Kingdom

PHD :: Biochemistry

University of California San Francisco

United States

MSC :: Cancer

Publications

Ahmet Buğra Tufan, Katina Lazarow, Marina Kolesnichenko, Anje Sporbert, Jens Peter von Kries, Claus Scheidereit
TSG101 associates with PARP1 and is essential for PARylation and DNA damage-induced NF-κB activation. The EMBO journal 41 (21) (2022)
Cristina Brischetto, Karsten Krieger, Christian Klotz, Inge Krahn, Séverine Kunz, Marina Kolesnichenko, Patrick Mucka, Julian Heuberger, Claus Scheidereit, Ruth Schmidt-Ullrich
NF-κB determines Paneth versus goblet cell fate decision in the small intestine. Development (Cambridge, England) 148 (21) (2021)
Marina Kolesnichenko, Nadine Mikuda, Uta E Höpken, Eva Kärgel, Bora Uyar, Ahmet Bugra Tufan, Maja Milanovic, Wei Sun, Inge Krahn, Kolja Schleich, Linda von Hoff, Michael Hinz, Michael Willenbrock, Sabine Jungmann, Altuna Akalin, Soyoung Lee, Ruth Schmidt-Ullrich, Clemens A Schmitt, Claus Scheidereit
Transcriptional repression of NFKBIA triggers constitutive IKK- and proteasome-independent p65/RelA activation in senescence. The EMBO journal 40 (6) (2021)
Nadine Mikuda, Ruth Schmidt-Ullrich, Eva Kärgel, Laura Golusda, Jana Wolf, Uta E Höpken, Claus Scheidereit, Anja A Kühl, Marina Kolesnichenko
Deficiency in IκBα in the intestinal epithelium leads to spontaneous inflammation and mediates apoptosis in the gut. The Journal of pathology 251 (2) (2020)